SNIPR Biome ApS - Treating and Preventing Microbial Infections
Summary
USPTO published patent application US20260098259A1 assigned to SNIPR Biome ApS, covering methods for treating microbial infections including acute conditions such as sepsis, septicemia, SIRS, and septic shock. The application also discloses methods for controlling microbiologically influenced corrosion (MIC) and biofouling in industrial or domestic systems.
What changed
USPTO published patent application US20260098259A1 assigned to SNIPR Biome ApS, covering methods for treating or preventing microbial (bacterial) infections. The application specifically addresses treatment of acute conditions including septicemia, sepsis, SIRS, and septic shock, as well as infections in immunocompromised subjects such as transplant, cancer, or autoimmune disease patients. The application also covers methods for controlling microbiologically influenced corrosion (MIC) and biofouling in industrial or domestic systems.
The patent application is currently pending examination. Pharmaceutical and biotechnology companies developing antimicrobial treatments should monitor the application status, as the scope of claims, once granted, may affect competitive positioning in antimicrobial therapeutic development and treatment methodologies.
What to do next
- Monitor for updates on patent application status
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TREATING AND PREVENTING MICROBIAL INFECTIONS
Application US20260098259A1 Kind: A1 Apr 09, 2026
Assignee
SNIPR Biome ApS
Inventors
Morten SOMMER, Virginia MARTINEZ, Eric VAN DER HELM, Jakob Krause HAABER, Ana DE SANTIAGO TORIO, Christian GRØNDAHL, Jasper CLUBE
Abstract
The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid and durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is particularly useful, for example, for treatment of microbes such as for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system. The invention also useful for the treatment of pathogenic bacterial infections in subjects receiving a treatment for a disease or condition, such as a transplant or a treatment for cancer, a viral infection or an autoimmune disease.
CPC Classifications
C12N 15/11 A61K 38/465 A61K 39/3955 A61K 39/39558 A61P 31/04 C07K 16/2818 C07K 16/2827 C12N 2310/20 C12N 2320/30 C12N 2320/31 Y02A 50/30
Filing Date
2025-10-23
Application No.
19367025
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.